SPLISENSE
Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing mutations. The company has developed a compound to cure the lung disease in cystic fibrosis patients carrying a specific splicing mutation. It is also developing a targeted modulation approach to correct the splicing pattern of CFTR transcripts according to the specific mutation carried.
SPLISENSE
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2016-01-01
Address:
Jerusalem, Yerushalayim, Israel
Country:
Israel
Website Url:
http://www.splisense.com
Total Employee:
1+
Status:
Active
Total Funding:
28.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins
Similar Organizations
Antengene Corporation
Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Castle Creek Biosciences
Castle Creek Biosciences is focused on developing commercializing novel, personalized gene therapies for rare skin disorders.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Menten AI
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Q-State Biosciences
Q-State has developed world-leading technologies and proprietary approaches for probing rare and genetic CNS conditions.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Current Advisors List
Current Employees Featured
Founder
Investors List
Biotel
Biotel investment in Series B - Splisense
Integra Holdings
Integra Holdings investment in Series B - Splisense
Cystic Fibrosis Foundation
Cystic Fibrosis Foundation investment in Series B - Splisense
Israel Biotech Fund
Israel Biotech Fund investment in Series B - Splisense
OrbiMed
OrbiMed investment in Series B - Splisense
Integra Holdings
Integra Holdings investment in Seed Round - Splisense
Official Site Inspections
http://www.splisense.com
- Host name: s-vps-il-124.upress.io
- IP address: 88.218.116.68
- Location: Rehovot Israel
- Latitude: 31.8943
- Longitude: 34.8192
- Timezone: Asia/Jerusalem
